Lastly, in the effort to understand the relationship of PrPC and tau, we recently described the transcriptional control of PRNP promoter by tau, which in turn may explain the overexpression of PrPC in Initial stages of AD [41], but the biological meaning of this is unknown despite previous data concerning the role of PrPC in the control of tau expression. Here, MAPT is linked to Alzheimer disease.